Table 2. Association between CXCL8 protein expression and clinicopathological characteristics in cervical cancer patients.
| Characteristics | n | CXCL8 protein expression | P | |
|---|---|---|---|---|
| High (%) | Low (%) | |||
| Age (years) | ||||
| ≤50 | 52 | 31 (59.6) | 21 (40.4) | 0.527 |
| >50 | 56 | 30 (53.6) | 26 (46.4) | |
| Clinical stage | ||||
| I–IIA | 49 | 21 (42.9) | 28 (57.1) | 0.009 |
| IIB–IV | 59 | 40 (67.8) | 19 (32.2) | |
| Tumor size (cm) | ||||
| ≤4 | 68 | 39 (57.4) | 29 (42.6) | 0.812 |
| >4 | 40 | 22 (55.0) | 18 (45.0) | |
| Lymph node metastasis | ||||
| Absent | 65 | 34 (52.3) | 31 (47.7) | 0.282 |
| Present | 43 | 27 (62.8) | 16 (37.2) | |
| Distant metastasis | ||||
| Absent | 101 | 54 (53.5) | 47 (46.5) | 0.045 |
| Present | 7 | 7 (100) | 0 (0) | |
| Histological type | ||||
| Adenocarcinoma | 18 | 18 (100) | 0 (0) | <0.001 |
| Squamous cell carcinoma | 90 | 43 (47.8) | 47 (52.2) | |
| Histological grade | ||||
| Well | 49 | 18 (36.7) | 31 (63.3) | <0.001 |
| Moderately/poorly | 59 | 43 (72.9) | 16 (27.1) | |